Font: Financial Modeling Prep • Apr 20, 2026
Dynex Capital (NYSE:DX) is a prominent real estate investment trust, or REIT. This investment firm primarily focuses on acquiring and managing various mortgage-backed securities, which are complex financial products underpinned by residential home loans. The core of its business strategy is to actively manage this diverse portfolio of securities to generate consistent income from interest payments, ultimately benefiting its shareholders.
The company's recent first-quarter earnings report revealed an earnings per share (EPS) of $0.31, which fell slightly below analyst expectations. EPS is a crucial profitability metric, representing the portion of a company's profit allocated to each outstanding share of stock. However, as highlighted by Business Wire, the company also reported a GAAP net loss of $0.41 per common share for the same reporting period, impacting overall financial results.
Further impacting its financial performance, quarterly revenue stood at $79.25 million, significantly falling short of the estimated $89.18 million. This notable revenue miss contributed to a comprehensive loss of $0.41 per common share. This particular financial metric offers a broader perspective on the company's performance compared to net income alone, as it encompasses various other financial gains and losses not typically recorded on the standard income statement.
Despite these reported losses, Dynex Capital demonstrates proactive capital management. The company successfully raised $442 million in equity financing through new stock issuances and executed substantial net investment purchases totaling $6 billion. Its book value, a key indicator of financial health representing the company's total assets minus its liabilities, was reported at $12.60 per common share at the close of the quarter. Dynex Capital also announced a dividend of $0.51 per common share, offering a direct return to investors.
The company's debt-to-equity ratio stands at 5.65, indicating a substantial reliance on debt financing to fund its assets. To ensure it can meet its financial obligations, the company maintains robust liquidity, holding $1.3 billion in available cash and cash reserves.
|
TOVX§>
Theriva Biologics, Inc.
|
$0.41
59.41%
|
|
FCHL§>
Fitness Champs Holdings Limited Common Stock
|
$0.23
-37.22%
|
|
CTNT§>
Cheetah Net Supply Chain Service Inc.
|
$0.05
-42.50%
|
|
CMND§>
Clearmind Medicine Inc.
|
$1.14
58.42%
|
|
BYND§>
Beyond Meat, Inc.
|
$1.16
41.02%
|
|
ENVB§>
Enveric Biosciences, Inc.
|
$3.65
100.55%
|
|
WLDS§>
Wearable Devices Ltd.
|
$1.30
-13.91%
|
|
TZA§>
Direxion Daily Small Cap Bear 3X ETF
|
$5.00
-1.57%
|
|
LZMH§>
LZ Technology Holdings Limited Class B Ordinary Shares
|
$0.16
-10.71%
|
|
NVDA§>
NVIDIA Corporation
|
$202.06
0.19%
|